Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

KAL

Callisto (KAL)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:KAL
DataOraFonteTitoloSimboloCompagnia
25/05/201504:00Dow Jones NewsStrike Worsens Nigeria Fuel CrisisNASDAQ:KALKenya Airways Ltd.
04/10/201218:04Dow Jones NewsCameroon To Buy Two Boeing Aircraft -OfficialAMEX:KALCallisto Pharmaceuticals,
05/09/201113:03Dow Jones NewsKenya Airways To Buy 10 E190 Jets From Brazil's Embraer -ReportNASDAQ:KALKenya Airways Ltd.
14/04/201119:52Dow Jones NewsKenya Airways Reaches Deal With Boeing Over 787 DeliveryNASDAQ:KALKenya Airways Ltd.
08/06/201015:55Dow Jones NewsAir France-KLM Isn't Seeking M&A Deals Right Now - KLM CEONASDAQ:KALKenya Airways Ltd.
16/04/201014:20Dow Jones NewsUPDATE: SkyTeam In Talks With Candidates For ExpansionNASDAQ:KALKenya Airways Ltd.
08/07/200822:46Edgar (US Regulatory)Callisto Pharmaceuticals Inc - Current report filing (8-K)AMEX:KALCallisto Pharmaceuticals,
15/05/200822:05Edgar (US Regulatory)Callisto Pharmaceuticals Inc - Quarterly Report (10-Q)AMEX:KALCallisto Pharmaceuticals,
02/05/200820:04Edgar (US Regulatory)Callisto Pharmaceuticals Inc - Amended Statement of Ownership (SC 13G/A)AMEX:KALCallisto Pharmaceuticals,
24/04/200812:01Edgar (US Regulatory)Callisto Pharmaceuticals Inc - Notice of Effectiveness (EFFECT)AMEX:KALCallisto Pharmaceuticals,
16/04/200822:47Edgar (US Regulatory)Callisto Pharmaceuticals Inc - Securities Registration Statement (simplified form) (S-3)AMEX:KALCallisto Pharmaceuticals,
11/04/200822:07Business WireCallisto Pharmaceuticals, Inc. Receives Notice of Delisting From Amex - Subject to Appeal -AMEX:KALCallisto Pharmaceuticals,
28/03/200811:01Edgar (US Regulatory)Callisto Pharmaceuticals Inc - Annual Report (10-K)AMEX:KALCallisto Pharmaceuticals,
14/02/200819:57Edgar (US Regulatory)Callisto Pharmaceuticals Inc - Statement of Ownership (SC 13G)AMEX:KALCallisto Pharmaceuticals,
30/01/200819:55Edgar (US Regulatory)Callisto Pharmaceuticals Inc - Prospectus filed pursuant to Rule 424(b)(3) (424B3)AMEX:KALCallisto Pharmaceuticals,
25/10/200716:33Edgar (US Regulatory)Callisto Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)AMEX:KALCallisto Pharmaceuticals,
01/10/200723:01Edgar (US Regulatory)Callisto Pharmaceuticals Inc (Other) (8-K)AMEX:KALCallisto Pharmaceuticals,
28/09/200719:53Edgar (US Regulatory)Callisto Pharmaceuticals Inc (Other) (424B3)AMEX:KALCallisto Pharmaceuticals,
28/09/200716:54Edgar (US Regulatory)Callisto Pharmaceuticals Inc (Other) (4)AMEX:KALCallisto Pharmaceuticals,
20/09/200713:07PR Newswire (US)Callisto Pharmaceuticals Completes Enrollment of Phase II Trial of Atiprimod in Neuroendocrine CancerNASDAQ:KAL
29/08/200715:00PR Newswire (US)American Stock Exchange Accepts Callisto Pharamceuticals' Plan of Compliance and Extension to Regain Compliance with StandardsNASDAQ:KAL
11/08/200702:05PR Newswire (US)Hagens Berman Sobol Shapiro: Class Action Lawsuit Filed Against Korean Air LinesNASDAQ:KAL
09/08/200714:00PR Newswire (US)Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer PatientsNASDAQ:KAL
08/08/200714:00PR Newswire (US)Callisto Reports on Second-Quarter 2007 MilestonesNASDAQ:KAL
07/08/200714:00PR Newswire (US)Callisto Pharmaceuticals Raises $11.2 Million in Series B Preferred Stock FinancingNASDAQ:KAL
25/06/200714:00PR Newswire (US)Callisto Pharmaceuticals Opens Additional Site for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer PatientsNASDAQ:KAL
22/06/200723:05PR Newswire (US)Callisto Pharmaceuticals, Inc. Receives Notice From AMEXAMEX:KALCallisto Pharmaceuticals,
08/06/200716:30PR Newswire (US)Callisto Pharmaceuticals Files Suit Against Former Executive Vice President for Breach of Employment Agreement, Fraud, ConversioNASDAQ:KAL
24/05/200716:00PR Newswire (US)Callisto Pharmaceuticals Opens Fourth Site for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer PatientsNASDAQ:KAL
15/05/200718:24PR Newswire (US)Callisto Pharmaceuticals Announces Article Citing Atiprimod in Major Scientific News JournalNASDAQ:KAL
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:KAL
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network